Pasithea Therapeutics Corp. Quarterly Current Ratio in % from Q2 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Pasithea Therapeutics Corp. quarterly Current Ratio history and growth rate from Q2 2022 to Q3 2024.
  • Pasithea Therapeutics Corp. Current Ratio for the quarter ending September 30, 2024 was 675 %, a 51% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 675 -703 -51% Sep 30, 2024
Q2 2024 694 -1.08K -61% Jun 30, 2024
Q1 2024 839 -1.61K -65.7% Mar 31, 2024
Q4 2023 1.07K -2.66K -71.3% Dec 31, 2023
Q3 2023 1.38K -4.52K -76.6% Sep 30, 2023
Q2 2023 1.78K -5.59K -75.9% Jun 30, 2023
Q1 2023 2.45K Mar 31, 2023
Q4 2022 3.73K Dec 31, 2022
Q3 2022 5.9K Sep 30, 2022
Q2 2022 7.37K Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.